Fernando Vieira

Company: ALS Therapy Development Institute

Job title: CEO and Chief Science Officer

Seminars:

An On-Going ALS Natural History Study to Distinguish Patient Subpopulations & Identify Novel Biomarkers 9:00 am

• Identifying biomarkers to distinguish ALS patient subpopulations for optimized clinical trial recruitment • Connecting biomarkers and target discovery to reveal ALS biology engaged in different subpopulations • Building data to apply approaches for predicting ALS susceptibility and early disease diagnosisRead more

day: Day Two AM